SB2362: Drug Shortage Prevention Act of 2023
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical drugs of increased demand, and for other purposes.
Plain-language summary
This bill would require drug manufacturers to notify federal health officials when they expect shortages of critical medications due to increased demand. The bill amends the Federal Food, Drug, and Cosmetic Act, which sets rules for drug safety and approval. Critical drugs are essential medications that treat serious health conditions and have few alternatives. The notification requirement aims to help the government prepare for and prevent shortages. The bill is currently in the early stage after being introduced in Congress.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
SB2362: Drug Shortage Prevention Act of 2023
Upcoming hearings & events
Sponsors
Amy Klobuchar
Primary SponsorCo-sponsors (6)
Susan Collins
Tina Smith
Lisa Murkowski
Elizabeth Warren
Gary Peters